Infectious Disease CME

Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are bloodborne and transmitted primarily through sexual contact and injection drug use (IDU). They have shared routes of transmission and therefore involve not only risk of infection for each of the three viruses but also coinfection. Studies have demonstrated increased liver-related deaths among coinfected individuals, which is a leading cause of death in HIV-infected individuals. Other complications include kidney disease, cardiovascular disease, metabolic disorders, and bone complications.

The goal of the CME Outfitters Infectious Disease Hub is to provide clinicians and patients with access to education in order to address the challenges in screening and treating patients with HIV and/or HBV/HCV. Links to dedicated patient education hubs offer tools to improve health literacy and engage patients to be active participants in their treatment plan.

Activities

Opening the Door to Trust: Discussing HIV Risk Assessment and Prevention with Adolescents

Session 2

Live Webcast | Monday, June 21, 2021 | 12:00 PM – 1:00 PM ET

Register Now

Session 3

Live Webcast | Monday, June 28, 2021 | 12:00 PM – 1:00 PM ET

Register Now

 

Thinking Long-Term: Data-Driven Decisions about PrEP

Session 1

Live Webcast | Thursday, July 15, 2021 | 12:00 PM – 1:00 PM ET

Register Now

Session 2

Live Webcast | Thursday, July 22, 2021 | 12:00 PM – 1:00 PM ET

Register Now

Session 3

Live Webcast | Friday, July 30, 2021 | 12:00 PM – 1:00 PM ET

Register Now

 

Bench to Bedside OnDemand: The Growing (Anti)body of Evidence for the Treatment of Mild-to-Moderate COVID-19

Participate Now

This CME Outfitters Live and OnDemand on early intervention treatments following diagnosis of COVID-19 as a way to reduce progression to severe disease will include the latest data on the efficacy and safety of mAb therapies and strategies for addressing knowledge and practice barriers to improve patient access to these therapies.

Earn a digital badge! 

Creating Action Steps for Linking Underserved Populations with Hepatitis C Care

Participate Now

In this CME Outfitters Live and OnDemand webcast, expert faculty will discuss the many barriers to treating HCV in the IDU population, including stigma and established negative perceptions about people who inject drugs (PWID), with special attention paid to applying CDC universal screening guidelines to improve diagnosis and linkage to treatment, expanding treatment for HCV in primary care settings, and addressing disparities in HCV treatment initiation in underserved communities.

Test Your Knowledge: An Interactive Session on Emerging Data and Expert Insights on Hepatitis B

Participate Now

Chronic hepatitis B (HBV) imposes a significant disease burden, and identifying those at risk for HBV is imperative to implementing effective care. Test your knowledge during this interactive CME Outfitters OnDemand webcast, featuring augmented reality animations that will reinforce the fibrotic consequence of untreated HBV. Data presentation and translation will showcase the importance of implementing routine screening protocols, optimizing efficacy and safety profiles of current agents when initiating or switching treatment, and routinely monitoring patients with HBV for disease progression, hepatocellular carcinoma, and HBV reactivation.

Streamlining the Journey to a Cure: Optimizing the Hepatitis C Virus Care Cascade

Participate Now

Recent studies have shown persistent gaps in the HCV care continuum, with underdiagnosis and undertreatment being the major barriers toward achieving the goal of eliminating HCV. With primary care clinicians and community health workers representing an important front-line resource for early screening and treatment for HCV infection, it is imperative to educate primary care providers (PCPs) and community health workers to expand the HCV workforce and linkage-to-care opportunities. This CME Outfitters on-demand webcast features expert faculty hosting an interactive discussion on implementing HCV screening, developing new methods of coordinated care, and addressing barriers to treatment access.

At-Risk Patients Hidden in Plain Sight: Real-World Strategies for Screening and Treating Hepatitis B Virus

Participate Now

In this CME Outfitters virtual symposium, expert faculty utilized augmented reality to add visualization to their discussion of how to implement routine screening protocols for HBV in primary care settings, how to optimize the efficacy and safety profiles of current agents, and the importance of providing culturally appropriate counseling and support services to patients, which will ensure understanding of their disease and promote retention in care.

A Grassroots Approach to Weed Out HIV and HCV in Special OUD Populations

Participate Now

In this CME Outfitters Live and OnDemand webcast, expert faculty discuss strategies for HIV and HCV testing in special OUD populations, applying evidence-based treatment approaches, as well as prevention strategies, including PrEP, for patients with OUD at high risk for HIV infection.

Overcoming Challenges in HIV and HCV Testing and Linkage to Care

Participate Now

The first part of this CME Outfitters BriefCase, a case-based faculty interview, examines a real-world case highlighting strategies for testing at-risk patients for HIV and HCV, including OUD populations. Further, faculty discuss how to interpret lab results and the appropriate steps to take for this patient population.

Comprehensive Approaches for HIV Prevention in High-Risk Patients with OUD

Participate Now

The second part of this CME Outfitters BriefCase, a case-based faculty interview, aims to educate clinicians on PrEP for HIV prevention, including what patients are—or are not—candidates for PrEP, as well as the necessary steps to take before initiating PrEP.

Management of a Patient with HIV-HCV Coinfection and Substance Use Disorder

Participate Now

The final installment of this three-part CME Outfitters BriefCase, a case-based faculty interview, features expert faculty discussing implementation of team-based approaches for the management of patients with HIV-HCV coinfection and substance use disorder in order to improve care for these patients.

Implementing a Shingles Protocol in Primary Care Settings

Participate Now

The first episode of this CMEOCast podcast series focuses on reinforcing the importance of vaccination against shingles, improving vaccination uptake in ethnic minorities and at-risk patients, and developing best practices to implement a shingles protocol in primary care settings.

Implementing a Shingles Protocol in Pharmacies

Participate Now

This CMEOCast podcast features expert faculty focusing on best practices to increase vaccine uptake by engaging and educating patients in pharmacy settings.

Implementing a Shingles Protocol in Specialty Practices

Participate Now

This CMEOCast podcast focuses on best practices to increase vaccine uptake and completion in vaccine-eligible patients and those at risk who present to specialty settings. The podcast will address ideal strategies to store and administer RZV, counseling patients on the extensive burden associated with shingles, and the benefits and potential risks of vaccination.

The HBV Refresher: Screen, Diagnose, Treat

Participate Now

Despite updated guidance from the American Association for the Study of Liver Diseases (AASLD) on the prevention, diagnosis, and treatment of chronic hepatitis B virus (HBV), early detection and implementation of effective treatment remains a challenge.

The first episode of this CMEOcast series on community-based efforts to improve screening and treatment of HBV will guide primary care clinicians through optimal strategies to screen for HBV in at-risk patients and utilize serological test results to drive guideline-directed care.

HBV Treatment Decision-Making

Participate Now

In this second episode of the four-part CMEOCast Podcast to Practice series “Meeting Patients Where They Live: Community-Based Efforts to Improve Screening and Treatment of HBV,” faculty experts will discuss the efficacy and safety profiles of current agents for HBV, guiding clinicians through best practices when initiating or switching treatment. In addition, while there is currently no cure for HBV, considering the promise for the future, faculty experts will define “functional cure” for HBV and its application to agents in development.

Public Health Opportunities in the ED: Step 1: Screen for HBV, Step 2: Link to Care

Participate Now

The third episode of this CMEOCast podcast series focuses on best practices for screening for HBV in the ED, incorporating the use of interprofessional teams, and fostering patient education for optimal treatment outcomes.

Long-Term Management of HBV: Meeting the Culturally Diverse Needs of Your Patient Community

Participate Now

Despite the high prevalence of hepatitis B virus (HBV) in the United States, only 32% of patients are aware of their HBV status and less than 30% receive treatment. There are six groups who are at especially high risk: foreign-born Asian/Pacific Islanders, Africa-born Black populations, incarcerated persons, people who inject drugs, men who have sex with men, and refugees. Disease awareness is especially low in many of these populations. In conjunction, the disease burden is compounded by cultural and societal barriers that often impede screening, prevention, and linkage to care.

This CME Outfitters podcast episode aims to provide learners with strategies to provide culturally appropriate counseling and support services to high-risk populations in order to optimize retention and long-term HBV care.

Pull the Levers That You Can: Managing HIV in an Aging Population

Participate Now

Currently, 48% of people diagnosed with human immunodeficiency virus (HIV) in the United States are age ≥ 50, and as the HIV-infected population ages it becomes increasingly important to identify comorbidities and consider them when optimizing treatment decisions, as they can involve risk of cardiovascular complications, renal disease, osteoporosis, and bone fracture.

 

In this CME Outfitters BriefCase, expert faculty will present a patient case focusing on the impact of comorbidities and how to individualize treatment regimens for aging patients with HIV, based on their specific needs and comorbidities.

 When Is Switching ART Necessary?

Participate Now

In the setting of viral suppression, there are many reasons to optimize antiretroviral therapy (ART); however, there are also factors to consider before switching or simplifying therapy, including the patient’s full treatment history and preference. After switching, it is imperative to monitor for potential side effects that could result in discontinuation, especially as long-term ART exposure contributes to the burden of renal disease.

 

In this CME Outfitters BriefCase, faculty will highlight a patient case that focuses on seizing opportunities to optimize and simplify treatment for patients with human immunodeficiency virus (HIV) while maintaining virologic suppression, as well as best practices for engaging patients in shared decision-making so that patient preference is always considered.

Choosing ART: What Does the Evidence Say?

Participate Now

There have been many recent therapeutic advances in human immunodeficiency virus (HIV), aiming to improve rates of viral suppression, reduce treatment burden, and improve treatment adherence. Current HIV guidelines provide recommendations for managing patients with HIV, including treatment initiation, therapy switching, and individualized treatment regimens for special populations. Rapid antiretroviral therapy (ART) initiation is imperative for early virologic suppression after HIV infection, as it improves health outcomes and decreases transmission. All individuals living with HIV should be offered ART following a confirmed diagnosis, with same-day initiation available. However, despite the benefits of early treatment, ART initiation is often delayed.

 

This CME Outfitters BriefCase focuses on incorporating the latest evidence-based and guideline-directed treatment strategies for a patient who has been newly diagnosed with HIV.

Clinician Resources

HIV

CDC HIV PrEP Guidelines 2017

Evidence of HIV Treatment and Viral Suppression in Preventing the Sexual Transmission of HIV

Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women

Recommended Laboratory HIV Testing Algorithm for Serum or Plasma Specimens

Recommendations for HIV Screening of Gay, Bisexual, and Other Men Who Have Sex with Men

Evaluation Toolkit: Patient and Provider Perspectives of HIV Screening in Health Care Settings

HCV

AASLD-IDSA Recommendations for Testing, Managing, and Treating HCV

CDC Recommended Testing Sequence for Identifying HCV

Recommendation Statement: Hepatitis C Virus in Adolescents and Adults_Screening - US Preventive Services Task Force

Guide to Comprehensive Hep C Counseling and Testing

HIV-HCV Co-Infection

Clinician Guidance for Patients with HIV/HCV Coinfection

Patient Resources

HIV

PrEP 101 Info 1-Pager for Patients

5 Positive to HIV Care

Who Should Get Tested for HIV and Where - Meaning of Results

HCV

AASLD-IDSA Recommendations for Testing, Managing, and Treating HCV

Hep C - What to Expect When Getting Tested

Hep C and Injection Drug Use

Hep C General Fact Sheet